GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qrons Inc (OTCPK:QRON) » Definitions » 14-Day RSI

Qrons (QRON) 14-Day RSI : 69.38 (As of Dec. 14, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Qrons 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-12-14), Qrons's 14-Day RSI is 69.38.

The industry rank for Qrons's 14-Day RSI or its related term are showing as below:

QRON's 14-Day RSI is ranked worse than
95.8% of 1523 companies
in the Biotechnology industry
Industry Median: 45.72 vs QRON: 69.38

Competitive Comparison of Qrons's 14-Day RSI

For the Biotechnology subindustry, Qrons's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qrons's 14-Day RSI Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Qrons's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Qrons's 14-Day RSI falls into.



Qrons  (OTCPK:QRON) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qrons  (OTCPK:QRON) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Qrons 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Qrons's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Qrons Business Description

Traded in Other Exchanges
N/A
Address
28-10 Jackson Avenue, No. 26N, Long Island, NY, USA, 11101
Qrons Inc is a biotechnology company developing advanced cell-based solutions to combat neuronal injuries with a laser focus on traumatic brain injuries. The technology would treat a wide range of neurodegenerative diseases. The treatment integrates proprietary, engineered mesenchymal stem cells, 3D printable scaffolding, smart materials, and a novel delivery system. The company has two product candidates, QS100TM for treating penetrating brain injuries and QS200TM, for treating concussions and other diffused axonal injuries.
Executives
John N Bonfiglio officer: Chief Operating Officer C/O MICROLIN BIO, INC., NEW YORK NY 10022
Jonah Meer director, 10 percent owner, officer: CEO, CFO and Secretary 28-10 JACKSON AVENUE, #26N, LONG ISLAND CITY NY 11101
Ido Merfeld director, 10 percent owner, officer: President 153 HAGILBOA STREET, NIRIT L3 44805

Qrons Headlines

From GuruFocus

Qrons Exercises Dartmouth Option

By ACCESSWIRE AccessWire 04-12-2019